2024 SCIEX Biopharma meeting (Day 2): Gene therapy, vaccines and oligonucleotides

The technologies presented will be CE and LC-MS.

The presentations will also be available on demand after the virtual event.

(Day 2): Gene therapy, vaccines and oligonucleotides

10:00–10:10 Welcome and introduction

• Steve Lock, SCIEX, UK

10:10–10:35 The latest developments in plasmid analysis by CE

• Luiza Chrojan / Ryan Hylands, Pharmaron, UK

10:35–11:00 Pure and simple: understanding LNP analytics for better mRNA-based drugs

• Adam Crowe, Cytiva, Canada

11:00–11:25 Tips and tricks to speed up CE-SDS analysis

• Marcus Heinl, SCIEX, Germany

11:25–11:35 Break

11:35–12:00 Applying CE to viral vector analysis of process samples

• Juliette Laigle / Yolande Masson, Yposkesi, France [NEW SPEAKERS]

12:00–12:25 Exploring mRNA mapping and aggregation analyses for mRNA characterization

• Lucia Geis Asteggiante, Phenomenex, Italy

12:25–12:50 After the experiment: electronic lab execution as standard

• Marc Smith, IDBS, UK [NEW SPEAKER]

12:50–13:00 Wrap-up and Q&A

Your host: Steve Lock, PhD (Senior Marketing and Market Development Manager, Biopharma, EMEAI, SCIEX)

Steve obtained his PhD in Physical Organic Chemistry from the University College of Swansea in 1993 and is a chartered chemist and a member of the Royal Society of Chemistry. He has worked for SCIEX in various technical roles for over 20 years and has presented at over 80 international meetings around the world. He currently works closely with customers in the biopharmaceutical industry. Steve is also currently an Adjunct Professor at the University of Pannonia.